Medytox to build plant for finished toxin products in Dubai

The company through his deal with a UAE public entity will become the first from Korea to build such a factory abroad

Marwan Abdulaziz Janahi, CEO of Dubai Science Park(left) and Jung Hyunho, CEO of Medytox
Marwan Abdulaziz Janahi, CEO of Dubai Science Park(left) and Jung Hyunho, CEO of Medytox
Min-Soo Han 1
2023-01-17 15:13:57 hms@hankyung.com
Bio & Pharma

South Korea's biopharmaceutical company Medytox Inc. will build a plant for finished products containing botulinum toxin in the United Arab Emirates (UAE) in what will be the first such facility abroad constructed by a Korean company.

The company on Tuesday said it signed a memorandum of understanding (MOU) with Dubai Science Park owned by Tecom Group, a Dubai government-run company, on construction of a plant for making finished toxin products. Medytox is also taking part in Korean President Yoon Suk-yeol's economic mission to the UAE that began on Saturday.

Medytox said it considered construction of production facilities abroad with several foreign companies to take on the global toxin market. The company picked Dubai thanks to its easy access to the Middle East and Europe and an excellent environment.

When completed, the Dubai plant will make Medytox the first Korean company to build a factory abroad for finished toxin products. The company started talks on action plans for the facility and will sign the main contract after such discussions.

"Our halal-certified factory for finished toxin products in Dubai will serve as a base for Medytox's toxin drugs to advance to the global market," Medytox CEO Jung Hyunho said.

Write to Min-Soo Han at hms@hankyung.com
#Medytox #UAE #plant #Dubai Science Park #Tecom Group #korea medytox dubai plant

S.Korea's Bioneer forms diagnostic joint venture with Indonesian company

S.Korea's Bioneer forms diagnostic joint venture with Indonesian company

South Korea's biotech company Bioneer Corp. on Monday said it concluded a deal to form a joint venture with PT Indika Energy of Indonesia for business cooperation in health care diagnostics and life science.The joint venture Bioneer Indica Group is headquartered in Jakarta. Based on its geneti

Korean biotechs target US labs to speed up regulatory approval for tests

Korean biotechs target US labs to speed up regulatory approval for tests

NGeneBio CEO Choi Dae-chul South Korean molecular diagnostics companies are increasingly buying high-quality laboratories in the US that meet federal regulatory standards in a bid to accelerate clinical studies.NGeneBio Co., a Seoul-based next-generation sequencing (NGS) services provider, biot

Medytox-Hugel dispute over botox strain intensifies with ITC probe

Medytox-Hugel dispute over botox strain intensifies with ITC probe

Hugel is Korea’s largest botox maker A legal dispute over a botox strain between South Korean pharmaceutical company Medytox Inc. and its crosstown rival Hugel Inc. has intensified with the International Trade Commission (ITC) officially launching an investigation into the case.The US tra

Medytox files complaint with ITC against Hugel over botox strain

Medytox files complaint with ITC against Hugel over botox strain

Korean botox maker Medytox South Korean pharmaceutical company Medytox Inc. has filed a complaint with the International Trade Commission (ITC) against Hugel Inc., alleging that the crosstown rival has poached its botulinum toxin strain.Hugel, Korea’s largest manufacturer of botulinum tox
(* comment hide *}